GlassScriptPhysician profile
Lisa Hrina
NPI 1346646262
$4,345.41
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,240 · 2022: $994 · 2023: $1,631 · 2024: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,111.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,086.92 | 2021-2024 | |
| Corium, LLC | $571.54 | 2021-2024 | Azstarys |
| Axsome Therapeutics, INC. | $415.26 | 2022-2024 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $333.17 | 2021-2024 | Caplyta |
| Ironshore Pharmaceuticals INC. | $235.59 | 2021-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $209.15 | 2021-2023 | Qelbree |
| Neurocrine Biosciences, INC. | $98.20 | 2021-2023 | Ingrezza |
| Janssen Pharmaceuticals, INC | $89.15 | 2022-2023 | Invega Sustenna |
| Tris Pharma INC | $81.58 | 2022-2023 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $79.02 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $59.89 | 2023 | Rexulti, Abilify Maintena |
| Adlon Therapeutics L.P. | $32.53 | 2021 | |
| Alkermes, INC. | $20.50 | 2023 | Aristada, Lybalvi |
| Tempus Ai, INC | $16.62 | 2024 | |
| Neos Therapeutics, LP | $16.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Hrina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.